Subclonal Diversity: Prognostic Role in Acute Myeloid Leukemia Patients with Minimal Residual Disease

Project: Research project

Project Details

Description

Subclonal Diversity: Prognostic Role in Acute Myeloid Leukemia Patients with Minimal Residual Disease Subclonal Diversity: Prognostic Role in Acute Myeloid Leukemia Patients with Minimal Residual Disease
StatusFinished
Effective start/end date1/1/1712/31/17

Funding

  • Mayo Clinic Jacksonville: $39,588.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.